Although BAY 11-7082 is a known inhibitor of NF-κB, there have been no direct clinical studies conducted in patients with IAs, but it is a tool to track the inflammatory pathway associated with other types of aneurysms [46,47]. The gene discussed is NFKB1; the disease is aneurysm.